6.62
price up icon0.00%   0.03
 
loading
Schlusskurs vom Vortag:
$6.65
Offen:
$6.58
24-Stunden-Volumen:
16,092
Relative Volume:
0.05
Marktkapitalisierung:
$21.27M
Einnahmen:
$1.22M
Nettoeinkommen (Verlust:
$-22.43M
KGV:
-5.7247
EPS:
-1.1564
Netto-Cashflow:
$-18.78M
1W Leistung:
-1.92%
1M Leistung:
+768.15%
6M Leistung:
+1,156%
1J Leistung:
+710.98%
1-Tages-Spanne:
Value
$6.51
$6.69
1-Wochen-Bereich:
Value
$6.51
$7.0399
52-Wochen-Spanne:
Value
$0.475
$7.299

Longeveron Inc Stock (LGVN) Company Profile

Name
Firmenname
Longeveron Inc
Name
Telefon
305-302-7158
Name
Adresse
1951 NW 7TH AVENUE, MIAMI
Name
Mitarbeiter
38
Name
Twitter
Name
Nächster Verdiensttermin
2026-11-03
Name
Neueste SEC-Einreichungen
Name
LGVN's Discussions on Twitter

Compare LGVN vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
LGVN icon
LGVN
Longeveron Inc
6.67 21.20M 1.22M -22.43M -18.78M -1.1564
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
521.27 134.06B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
803.21 83.43B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
1,006.01 63.00B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
137.71 56.02B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
210.29 44.44B 742.00K -1.37B -1.07B -7.0731

Longeveron Inc Stock (LGVN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-06 Eingeleitet ROTH MKM Buy

Longeveron Inc Aktie (LGVN) Neueste Nachrichten

pulisher
Sep 05, 2026

LGVN Stock Slips After Hours As FDA Flags Concerns On Rare Heart Defect Trial Design - Stocktwits

Sep 05, 2026
pulisher
Sep 05, 2026

LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty Study - Stocktwits

Sep 05, 2026
pulisher
Sep 05, 2026

Longeveron Stock Price Forecast. Should You Buy LGVN? - StockInvest.us

Sep 05, 2026
pulisher
Sep 04, 2026

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Longeveron Inc. of Class Action Lawsuit and Upcoming DeadlineLGVN - TMX Newsfile

Sep 04, 2026
pulisher
Sep 03, 2026

Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times

Sep 03, 2026
pulisher
Sep 03, 2026

A biotech presentation is set for New York on Sept. 14 - Stock Titan

Sep 03, 2026
pulisher
Sep 01, 2026

Longeveron | 4: Statement of changes in beneficial ownership of securities - Moomoo

Sep 01, 2026
pulisher
Aug 31, 2026

Longeveron (LGVN) Gains 2.68% as Shares Hold Above Key Support at $6.55Breakout Confirmation - vinanet.vn

Aug 31, 2026
pulisher
Aug 25, 2026

Longeveron To Carry Out 1-for-10 Reverse Stock Split On August 27th, 2026 - Moomoo

Aug 25, 2026
pulisher
Aug 25, 2026

Longeveron Announces 1-for-10 Reverse Stock Split to Regain Nasdaq Compliance - Intellectia AI

Aug 25, 2026
pulisher
Aug 25, 2026

Dick's Sporting Goods, Intuit And 3 Stocks To Watch Heading Into Tuesday - sahmcapital.com

Aug 25, 2026
pulisher
Aug 24, 2026

Longeveron Announces 1-for-10 Reverse Stock Split - The National Law Review

Aug 24, 2026
pulisher
Aug 24, 2026

Longeveron Announces 1-For-10 Reverse Stock Split - TradingView

Aug 24, 2026
pulisher
Aug 22, 2026

Longeveron Inc. Earnings Call: Trials, Cash and Risk - TipRanks

Aug 22, 2026
pulisher
Aug 21, 2026

Longeveron (NASDAQ: LGVN) insider logs new stock trades - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

Longeveron (LGVN) grants director 36,000 stock units - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

Longeveron (NASDAQ: LGVN) insider reports new stock dealings - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

Longeveron (NASDAQ: LGVN) insider reports stock trades - Stock Titan

Aug 21, 2026
pulisher
Aug 20, 2026

Longeveron (LGVN) Q2 2026 Earnings Call Transcript - AOL.ca

Aug 20, 2026
pulisher
Aug 20, 2026

Longeveron (LGVN) Earnings Reading: Profit Per Share Falls Below Its Benchmark at the Close; After Results: The Stock Gains 4.46% in the Current UpdateEarnings Sentiment Score - dars.gov.et

Aug 20, 2026
pulisher
Aug 19, 2026

Longeveron appoints Nirav Jhaveri as chief financial officer - Investing.com Nigeria

Aug 19, 2026
pulisher
Aug 19, 2026

Longeveron Appoints Nirav Jhaveri as CFO Ahead of September Trial Data - Minichart

Aug 19, 2026
pulisher
Aug 19, 2026

symbol__ Stock Quote Price and Forecast - CNN

Aug 19, 2026
pulisher
Aug 19, 2026

Longeveron CFO Marie Washburn to switch roles, Nirav Jhaveri to succeed - TipRanks

Aug 19, 2026
pulisher
Aug 19, 2026

Longeveron Appoints New Chief Financial Officer Jhaveri - TipRanks

Aug 19, 2026
pulisher
Aug 19, 2026

Longeveron Appoints Nirav Jhaveri as Chief Financial Officer - The Manila Times

Aug 19, 2026
pulisher
Aug 19, 2026

Longeveron Appoints Nirav Jhaveri As CFO - marketscreener.com

Aug 19, 2026
pulisher
Aug 19, 2026

Longeveron appoints Nirav Jhaveri as chief financial officer By Investing.com - Investing.com India

Aug 19, 2026
pulisher
Aug 19, 2026

Longeveron Inc. Appoints Nirav Jhaveri as Chief Financial Officer - Quiver Quantitative

Aug 19, 2026
pulisher
Aug 18, 2026

Marie Washburn Net Worth (2026) - GuruFocus

Aug 18, 2026
pulisher
Aug 17, 2026

Longeveron reports Q2 EPS (19c) vs. (33c) last year - TipRanks

Aug 17, 2026
pulisher
Aug 17, 2026

$Longeveron (LGVN.US)$ - Moomoo

Aug 17, 2026
pulisher
Aug 13, 2026

Longeveron Inc. (LGVN) investors disclose 9% beneficial stake through warrant holdings - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

Longeveron LLC earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria

Aug 13, 2026
pulisher
Aug 13, 2026

Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update - BioSpace

Aug 13, 2026
pulisher
Aug 12, 2026

Longeveron Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Aug 12, 2026
pulisher
Aug 12, 2026

Longeveron Q2 EPS $(0.19) Misses Estimate, Sales Fall 9% - scanx.trade

Aug 12, 2026
pulisher
Aug 12, 2026

LGVN: Q2 2026 net loss rose to $6.1M as HLHS trial data and XPRIZE finalist status drive near-term focus - TradingView

Aug 12, 2026
pulisher
Aug 12, 2026

Earnings call transcript: Longeveron misses Q2 2026 estimates as cash runs tight - Investing.com

Aug 12, 2026
pulisher
Aug 12, 2026

Longeveron Inc. (LGVN) Q2 FY2026 earnings call transcript - Yahoo Finance

Aug 12, 2026
pulisher
Aug 12, 2026

Longeveron Reports $6.1 Million Q2 Net Loss Ahead Of ELPIS II Data - Quiver Quantitative

Aug 12, 2026
pulisher
Aug 12, 2026

Longeveron Q2 net loss widens on higher legal, clinical trial costs - TradingView

Aug 12, 2026
pulisher
Aug 12, 2026

LGVN: Q2 2026 net loss rose 22% as clinical and legal expenses increased ahead of key trial results - TradingView

Aug 12, 2026
pulisher
Aug 12, 2026

BRIEF-Longeveron Q2 EPS USD -0.19 - TradingView

Aug 12, 2026
pulisher
Aug 12, 2026

Longeveron Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 12, 2026
pulisher
Aug 12, 2026

Longeveron (LGVN) Rises 7.92% to $0.75, Approaches Key Resistance at $0.79Dividend Arbitrage - dars.gov.et

Aug 12, 2026
pulisher
Aug 11, 2026

Earnings To Watch: Longeveron Inc (LGVN) Q2 2026 -- GF Value Sees 58% Downside - Yahoo Finance

Aug 11, 2026
pulisher
Aug 11, 2026

Longeveron Selected as XPRIZE Healthspan Milestone 2 Awardee for Laromestrocel Clinical Trial Results - Quiver Quantitative

Aug 11, 2026
pulisher
Aug 11, 2026

Longeveron Named a Finalist Team and Will Receive a - GlobeNewswire

Aug 11, 2026
pulisher
Aug 11, 2026

Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition - The Manila Times

Aug 11, 2026
pulisher
Aug 10, 2026

Longeveron Inc. (LGVN): Millennium group discloses 5.2% Class A equity stake - Stock Titan

Aug 10, 2026

Finanzdaten der Longeveron Inc-Aktie (LGVN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$60.13
price down icon 0.71%
$129.12
price up icon 2.84%
$41.64
price up icon 0.61%
$255.32
price down icon 1.75%
ONC ONC
$348.96
price down icon 0.72%
$209.70
price up icon 1.11%
Kapitalisierung:     |  Volumen (24h):